Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alfonso Berrocal, MD, PhD
Hospital General Universitario de Valencia
Principal Investigator - José Antonio López-Martín, MD, PhD
Hospital Universitario 12 de Octubre
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario Donostia
Donostia / San Sebastian, Guipuzcoa, Spain
- Hospital General Universitario Santa Lucía
Cartagena, Murcia, Spain
- Hospital Clínic de Barcelona
Barcelona, Spain
- Hospital Universitario Vall D'Hebron
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
- Hospital Insular de Gran Canaria
Las Palmas de Gran Canaria, Spain
- Hospital Universitario Lucus Augusti
Lugo, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario la Paz
Madrid, Spain
- Hospital Regional Universitario de Málaga
Málaga, Spain
- Hospital Clínico Universitario de Salamanca
Salamanca, Spain
- Hospital Universitario de Canarias
Santa Cruz de Tenerife, Spain
- Hospital Universitario Virgen Macarena
Seville, Spain
- Hospital General Universitario de Valencia
Valencia, Spain
- Hospital Universitario Doctor Peset
Valencia, Spain
- Hospital Universitario Y Politécnico la Fe
Valencia, Spain
- Hospital Álvaro Cunqueiro (complejo Hospitalario Universitario de Vigo)
Vigo, Spain
- Hospital Universitario Miguel Servet
Zaragoza, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2015
- Primary completion
- 30 Sept 2019
- Completion
- 30 Sept 2019
- Last update posted
- 17 Feb 2020
- Registered enrollment
- 70
- Registry id
- NCT02583516
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.